Advancing Minimally Invasive Care Okami Medical, a leader in the development of innovative interventional medical technologies, has announced a significant milestone. The company has received an expanded indication from the U.S. Food and Drug Administration (FDA) for its LOBO Vascular Occluder, a device designed to change the landscape of peripheral vascular interventions. What This Means…